Drug Channels: The Big Three PBMs' 2026 Formulary Exclusions: MFP, Private Label Biosimilars, and Direct to Patient Threats for PBMs Ozempic Bobble Head TikTok More people with type 1 diabetes are using GLP 1 drugs, study finds, despite limited evidence on safety or effectiveness CNN Well this is awkward If you think Ozempic proved people were just lazy, you've told on your lack of physiology knowledge, not theirs. Ozempic didn't disprove body positivity. It disproved the